ERBB2 and breast cancer: Estrogen receptor (ER), progesterone receptor (PR), and expression of the human epidermal growth factor receptor 2 (HER2) are classical immunohistochemistry markers that classify BC into four main molecular subtypes: luminal A, luminal B, HER2-enriched, and basal-like [3,4].